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The ﬁelds of tissue engineering and regenerative medicine aim at promoting the
regeneration of tissues or replacing failing or malfunctioning organs, by means of
combining a scaffold/support material, adequate cells and bioactive molecules. Different
materials have been proposed to be used as both three-dimensional porous scaffolds and
hydrogel matrices for distinct tissue engineering strategies. Among them, polymers of
natural origin are one of the most attractive options, mainly due to their similarities with
the extracellular matrix (ECM), chemical versatility as well as typically good biological
performance. In this review, the most studied and promising and recently proposed
naturally derived polymers that have been suggested for tissue engineering applications are
described. Different classes of such type of polymers and their blends with synthetic
polymers are analysed, with special focus on polysaccharides and proteins, the systems
that are more inspired by the ECM. The adaptation of conventional methods or non-
conventional processing techniques for processing scaffolds from natural origin based
polymers is reviewed. The use of particles, membranes and injectable systems from such
kind of materials is also overviewed, especially what concerns the present status of the
research that should lead towards their ﬁnal application. Finally, the biological
performance of tissue engineering constructs based on natural-based polymers is discussed,
using several examples for different clinically relevant applications.
Keywords: natural origin polymers; biomacromolecules; tissue engineering;
biomedical applications; biodegradable
1. INTRODUCTION
In the new paradigms of regenerative medicine, the use
of materials in contact with biological materials (cells,
tissues/organs, physiological ﬂuids and biomolecules) is
a current illustration of the need of interdisciplinary
scientiﬁc approaches that combine the most recent
advances in materials science and technology, basic
sciences and life sciences. In tissue engineering,
matrices are developed to support cells, promoting
their differentiation and proliferation towards the
formation of a new tissue. Such strategies allow for
producing hybrid constructs that can be implanted in
patients to induce the regeneration of tissues or replace
failing or malfunctioning organs. Different materials
have been proposed to be used in the processing of
scaffolds, namely biodegradable polymers. Natural-
based polymers offer the advantage of being similar to
biological macromolecules, which the biological
environment is prepared to recognize and deal with
metabolically. Owing to their similarity with the
extracellular matrix (ECM), natural polymers may
also avoid the stimulation of chronic inﬂammation or
immunological reactions and toxicity, often detected
with synthetic polymers. In this review, the different
natural-based materials that have been proposed to be
used in tissue engineering strategies will be overviewed.
An important aspect is also addressed, which is the
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processing of such kind of materials into porous
matrices, a task that usually needs other technologies
rather than those usually employed in the processing of
conventional synthetic polymers. There are also clinical
needs for processing biomaterials into other shapes,
including nano/microparticles (for control release
application), or into two-dimensional structures (e.g.
membranes as wound dressing). Non-invasive materials
containing cells and bioactive agents are very attractive
approaches in tissue engineering and regeneration
contexts, which will also be discussed. Section 7 is
devoted to the clinical applications of such materials
and their in vivo performance for different cases.
2. NATURAL-BASED POLYMERIC SYSTEMS
The design and selection of a biomaterial is a critical
step in the development of scaffolds for tissue
engineering. Generally, the ideal biomaterial should
be non-toxic, biocompatible, promoting favourable
cellular interactions and tissue development, while
possessing adequate mechanical and physical proper-
ties. In addition, it should be biodegradable and
bioresorbable to support the reconstruction of a new
tissue without inﬂammation (Kim et al. 2000). On the
other hand, novel concepts of tissue engineering are
imposing new and more speciﬁc requirements on
macromolecular components. Living organisms are
able to synthesize a vast variety of polymers, which
can be divided into major classes according to their
chemical structure: (i) polysaccharides, (ii) proteins,
and (iii) polyesters. Nowadays, with the advances in
biotechnology, natural polymers can be obtained by
the fermentation of micro-organisms (Widner et al.
2005) or produced in vitro by enzymatic processes
(Kobayashi et al. 2003). However, the largest amount
is still extracted from plant (Franz & Blaschek 1990;
Morrison & Karkalas 1990; Stephen et al. 1990) and
animal (Izydorczyk et al. 2005) sources or from algae
(Percival & McDowell 1990).
2.1. Materials inspired by the extracellular
matrix
The ECM is the optimized milieu that nature has been
developing to maintain homeostasis and to direct tissue
development. Therefore, a great effort has been made to
mimick theECMto guidemorphogenesis in tissue repair
and tissue engineering (Hubbell 2003). A strategy has
been proposed to isolate the main constituents of the
ECM and directly use them after puriﬁcation, with or
without further modiﬁcations. As ECM plays an
instructive role in cell activities, the hypothesis here is
that such biomolecules would maintain the biological
information and other physico-chemical features, which
would preserve a potential space for new tissue
development after cell seeding. This would help to
overcome one of the main drawbacks in the use of
synthetic materials, which lack cell recognition signals.
A description of some protein-based biomaterials
isolated from ECM follows. These materials are typi-
cally extracted from blood plasma and the skeleton.
Other functional proteins, including growth factors,
enzymes and interleukins, which are used essentially as
ingredients to be incorporated into biomaterials, will not
be discussed here.
Collagen is the most abundant protein in the body.
More than 20 genetically distinct forms have been
identiﬁed, type I being the most abundant and most
investigated for biomedical applications (Hayashi
1994). Characteristics such as high mechanical
strength, good biocompatibility, low antigenicity and
ability of crosslinking enable the tailoring of the
mechanical, degradation and water uptake properties.
To obtain matrices with adequate mechanical proper-
ties, chemical glycation procedures or heat treatments
have been proposed (Hubbell 2003). Combinations of
collagen with other materials have also been prepared.
For example, collagen microsponges may be easily
impregnated into previously prepared synthetic poly-
meric scaffolds, which will increase their mechanical
performance (Chen et al. 2000). On the other hand,
growth factors and other active agents can be combined
with collagen-based systems, including scaffolds and
gels to prolong their release rate and increase their
therapeutic effect on tissue engineering approaches
(Geiger et al. 2003; Wallace & Rosenblatt 2003).
Fibronectin is a multifunctional component of the
ECM, known to induce cell attachment and spreading
through its cell binding site and related synergy sites.
The ability of such glycoprotein (a disulphide-bonded
dimer of 220–250 kDa subunits) to serve as a substrate
for cell adhesion is based on the biological activity of
several modules: the RGD tripeptide, arginine-glycine-
aspartic acid, in the tenth Fn3 module plays here an
important role (Ruoslahti & Pierschbacher 1987) and
has been incorporated onto the surface of numerous
biomaterials; several strategies have been summarized
by Hubbell (2003). One of the suggested strategies was
to deposit layers of oriented ﬁbronectin to enhance the
availability of its cell binding site (Calonder et al. 2005).
On an oriented ﬁbronectin layer, compared with an
isotropic layer, human umbilical vein endothelial cells
spread signiﬁcantly faster in a more spherical way.
Glycosaminoglycans (GAGs) are linear chains con-
sisting of the repeating unit of a disaccharide, gener-
ically a hexosamine (glucosamine or galactosamine)
and a uronic acid component (Hayashi 1994). With the
exception of hyaluronic acid, such chains are attached
to a central protein to form the proteoglycans. Owing to
their ionic character, GAGs are able to absorb large
quantities of water, and this osmotic swelling provides
compressive strength.
Fibrin plays an important role in haemostasis and
spontaneous tissue repair (it naturally forms during
blood coagulation). Fibrin is a complex network formed
by polymerization of ﬁbrinogen in the presence of the
enzyme thrombin. Fibrinogen can be isolated from the
blood plasma of the patient, limiting its potential for
disease transmission and immunogenic reactions.
Fibrin is not a regular component of the ECM, but is
found as a temporary matrix that will be further
replaced by the ECM, and is currently used as ﬁbrin
glue in clinical applications. Fibrin has been a useful cell
delivery matrix for cartilage tissue engineering,
especially in combination with other biodegradable
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Table 1. Examples of some polysaccharides available in nature, their relevant properties and applications in the ﬁelds of tissue engineering and regenerative medicine.
polysaccharide source repeating unit relevant properties
examples of proposed
applications
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tapioca, etc.; Morrison
& Karkalas 1990)
O
H
H
HO
H
O
OH
H
CH
2
H
α-Amylose
α−D-Glucopyranose
OH
O
H
H
HO
H
O
HO
H
CH
2
H
OH
O
H
4 H
HO
H
O
OH
H
CH
2
H
HO
O
H 4 O
H
OH
H
O
OH
H
CH
2
H
HO
α
1
α1
α
1
α
1
4
4
n
O
H
H
HO
H
O
OH
H
CH
2
H
Amylopectin
O
H
H
HO
H
O
OH
H
CH
2
α(1 6) branch point
OH
O
H
H
HO H
O
OH
H
CH
2
H
OH
O
H
O
H
HO
H
O
OH
H
CH2
H
O
H
O
H
HO
H
O
OH
H
CH
2
H
α
1
α
1
α
1
H
OH
OH
α
1
α
1
4
6
4
4
4
4
n
starch is a highly available
material and can be easily
modiﬁed (crosslinked, oxi-
dized and acetylated; Xie
et al. 2005); it can be
converted into a thermo-
plastic (Rodriguez-
Gonzalez et al. 2004), or
blended with synthetic
polymers to improve the
weakness of starch and thus
obtain better mechanical
properties (Ciardelli et al.
2005); amylose forms gels
and ﬁlms; it is enzy-
matically degraded by
a-amylase (Azevedo et al.
2003), which exists in serum
starch-based scaffolds pro-
duced by melt-based
(Gomes et al. 2001, 2003;
Salgado et al. 2004a) and
rapid prototyping (Lam
et al. 2002; Pﬁster et al.
2004) techniques for bone
and other TE applications
cellulose plant (cotton, wood,
straw, etc.; Franz &
Blaschek 1990);
microbial (bacterial
cellulose, e.g. Aceto-
bacter xylinum;
Svensson et al. 2005)
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cellulose can be converted into
different derivatives (car-
boxymethylcellulose, cellu-
lose nitrate, cellulose
acetate, cellulose xanthate;
Franz & Blaschek 1990)
that can be easily moulded
or drawn into ﬁbres
(Entcheva et al. 2004)
cellulose acetate scaffolds for
cardiac TE (Entcheva
et al. 2004) and bacterial
cellulose for cartilage TE
(Svensson et al. 2005)
arabinogalactan
(larch gum)
plant (extracted from the
heartwood of the wes-
tern larch Larix
occidentalis;
Chandrasekaran &
Janaswamy 2002)
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this polymer is a highly
branched polysaccharide
with high water solubility
(70% in water; Stephen
et al. 1990; Ehrenfreund-
Kleinman et al. 2002)
arabinogalactan-based
sponges for TE
(Ehrenfreund-Kleinman
et al. 2002)
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Table 1. (Continued.)
polysaccharide source repeating unit relevant properties
examples of proposed
applications
alginic acid brown algae (Phaeophy-
ceae, mainly Lami-
naria); microbial
(bacteria Pseudomo-
nas mendocina, Azo-
tobacter vinelandii;
Percival & McDowell
1990)
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simple gelation with divalent
cations (e.g. Ca2C, Mg2C,
Ba2C, Sr2C); it is the size
and proportion of the G
blocks in the polymer chain
that determines the forma-
tion and strength of gels
formed with calcium
(Percival & McDowell
1990)
cell encapsulation matrix
(Jen et al. 1996; Rowley
et al. 1999; Kampf 2002);
injectable cell delivery
vehicle (Bouhadir et al.
2001); alginate scaffolds
for hepatic TE (Glicklis
et al. 2000); alginate
hydrogels for cartilage TE
(Awad et al. 2004; Mouw
et al. 2005)
agar red algae: Rhodophyceae
(Gelidium and Graci-
laria spp.; Percival &
McDowell 1990)
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Agarose
agarose forms thermally
reversible gels (cold setting
gels at approx. 388C);
however, the melting
temperature is much higher,
approximately 858C; this
gives agar gel a very large
gelling/melting hysteresis
(Izydorczyk et al. 2005)
agarose gels/sponges for car-
tilage (Awad et al. 2004;
Miyata et al. 2004; Mouw
et al. 2005; Ng et al. 2005),
disc TE (Gruber et al.
2006) and nerve regen-
eration (Balgude et al.
2001); production of ana-
tomically shaped, engin-
eered cartilage constructs
using chondrocyte-seeded
agarose hydrogels (Mauck
et al. 2003); cell encapsu-
lation matrix (Jen et al.
1996; O’Connor et al.
2001; Kampf 2002)
carrageenan red algae: Rhodophyceae
(Chondrus crispus,
Eucheuma cottonii,
Eucheuma spinosum;
Percival & McDowell
1990)
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presence of KC ions to form
strong crisp gels; i-carra-
geenan gels in the presence
of Ca2C ions to form elastic
gels; l-carrageenan is non-
gelling but forms viscous
solutions (Percival &
McDowell 1990)
carrageenan-based polyelec-
trolyte for cell encapsula-
tion (Prokop et al.
1998a,b; Bartkowiak &
Hunkeler 2001; Shumilina
& Shchipunov 2002)
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Table 1. (Continued.)
polysaccharide source repeating unit relevant properties
examples of proposed
applications
chitin animal (crustacean
shells, exoskeletons of
insects and other
arthropods); microbial
(fungal cell walls;
Lezica & Quesada-
Allue´ 1990)
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chitin is insoluble in most
common solvents, but can
be converted by chemical
reactions into soluble
derivatives (Kurita 2001);
chitin derivatives are enzy-
matically degraded by lyso-
zyme, which exists in blood
serum and phagocytic cells,
but the rate of degradation
depends on the DA (Freier
et al. 2005a)
chitosan ﬁbre mesh scaffolds
produced by wet spinning
for bone TE (Tuzlakoglu
et al. 2004); chitosan
sponges as scaffolding
materials for bone forma-
tion and cartilage TE
(Nettles et al. 2002; Seol
et al. 2004); chitin-based
tubes for nerve regen-
eration (Freier et al.
2005b); chitosan particles
agglomerated scaffolds for
cartilage and osteochon-
dral TE (Malafaya et al.
2005); injectable chitosan-
based cell delivery vehicle
for cartilage TE (Chenite
et al. 2000; Hoemann et al.
2005)
hyaluronic acid animal (synovial ﬂuid,
vitreous humour of the
eye, umbilical tissue;
Drury & Mooney
2003); microbial (fer-
mentation Bacillus
subtilis; Leach et al.
2003; Widner et al.
2005)
O
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HO
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OH
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O
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n
C O
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N-Acetyl-D-glucosamineD-Glucuronic acid
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3
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4
hyaluronan is soluble in water
and can form hydrogels by
covalent and photocros-
slinking with hydrazide
derivatives, by esteriﬁca-
tion and annealing; it is
enzymatically degraded by
hyaluronidase, which exists
in cells and serum (Drury &
Mooney 2003)
prototype benzylic ester of
hyaluronic acid scaffold
for ligament TE (Cristino
et al. 2005); hyaluronan-
based sponges for the
treatment of osteochon-
dral defects (Solchaga
et al. 2000), ﬂat sheets of
non-woven hyaluronan-
based scaffold as vascular
graft (Arrigoni et al.
2006); photocrosslinked
hyaluronic acid hydrogels
as TE scaffolds (Leach
et al. 2003)
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Table 1. (Continued.)
polysaccharide source repeating unit relevant properties
examples of proposed
applications
dextran microbial (bacterium
Leuconostoc mesen-
teroides; Naessens
et al. 2005)
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dextran is soluble in both
water and organic solvents
(e.g. dimethyl sulphoxide;
Jiang et al. 2004); it is stable
under mild acidic and basic
conditions, and contains a
large number of hydroxyl
groups available for modiﬁ-
cation/conjugation with
other molecules (Mehvar
2000)
porous hydrogels as scaffolds
for TE applications
(Levesque et al. 2005)
gellan gum microbial (bacterium
Sphingomonas elodea;
Ciardelli et al. 2005) O
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D-Glucopyranose D-Glucuronic acid
low acyl gellan gum
high acyl (HA) gellan gum
gives soft, elastic, transpar-
ent and ﬂexible gels at
polymer concentrations
higher than 0.2%; HA gels
set and melt at approxi-
mately 70–808C with no
thermal hysteresis;
however, low acyl (LA)
gellan gum can form hard,
non-elastic and brittle gels
in the presence of cations,
including Ca2C, Mg2C,
NaC, KC and HC; the gel
strength of LA gellan gum
increases with increasing
ion concentration; cation
concentration can also
affect gel setting and melt-
ing temperatures
(Izydorczyk et al. 2005)
laser sintered polycaprolac-
tone/gellan as TE scaf-
folds (Cascone et al. 2001;
Ciardelli et al. 2005)
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substances, such as alginate (Perka et al. 2000) or
hyaluronic acid (Park et al. 2005b). It has also been
used in the regeneration of the skin, with considerable
success, and even in the loading and posterior release of
growth factors (see Hubbell 2003 and references
therein).
Hydrogels enabling enzymatically mediated cell
migration are part of an interesting strategy to mimic
the ECM, whose aim is to develop matrices that could
promote cell ingrowth throughproteolytic degradation of
the matrix, usually requiring the action of metallopro-
teinases that are secreted by cells. Very elegant works
have reported the use of conjugates of poly(ethylene
glycol) and speciﬁc peptides that can be hydrolysed
under the presence of enzymes involved in cell migration
(Mann et al. 2001; Lutolf et al. 2003a). Growth factors
can be entrapped that can also promote mesenchymal
stem cell (MSC) inﬁltration and corresponding differen-
tiation (Lutolf et al. 2003a,b). Instead of peptide
segments, denaturated ﬁbrinogen segments were com-
bined with poly(ethylene glycol) to form biosynthetic
hybrid hydrogels (Almany & Seliktar 2005).
Self-assembling materials, also aimed at mimicking
the ECM, have been proposed as hydrogels for tissue
engineering applications. Peptide-amphiphilic-based
nanostructured ﬁbrous scaffolds were produced by
pH-induced self-assembly that could also induce
biomineralization (Hartgerink et al. 2001). A three-
dimensional network based on nanoﬁbres formed by the
self-assembly of peptide-amphiphilic molecules was also
used to encapsulate neural progenitor cells, showing the
ability to induce very rapid differentiation into neurons,
while discouraging the development of astrocytes (Silva
et al. 2004).
2.2. Other protein-derived biomaterials
Animal- or vegetal-derived proteins have been shown to
have potential to be used as scaffolds for tissue
engineering applications. Silk proteins, for example,
contain a highly repetitive primary sequence that leads
to a high content of b-sheets, responsible for the good
mechanical properties of silk ﬁbres. It has been reported
that silk ﬁbroin may have potential to be used in tissue
engineering applications, where mechanically robust,
long-term degradable materials are needed (Altman
et al. 2003). For example, highly porous silk scaffolds
were combined with adult MSCs for in vitro cartilage
tissue engineering (Wang et al. 2005). Additionally,
casein and soybean protein-based materials were found
to be promising materials for use in different biomedical
applications, including the production of scaffolds for
tissue engineering (Vaz et al. 2003). The major draw-
back of such materials is the possibility of eliciting some
level of foreign body response following implanta-
tion in vivo, which can be minimized, for instance,
by puriﬁcation.
2.3. Polysaccharides
Polysaccharides consist of monosaccharides linked
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chain shapes and molecular weight dictate their physical
properties, including solubility, ﬂow behaviour, gelling
potential and/or surface and interfacial properties.
Polysaccharides are derived from renewable resources,
namely plants, animals and micro-organisms, and are
therefore widely distributed in nature. They perform
differentphysiological functions andmayoffer a variety of
potential applications in the ﬁelds of tissue engineering
and regenerative medicine.
2.3.1. Plant polysaccharides. Starch is a mixture of
glycans that plants synthesize as their principal food
reserve. It is deposited in the chloroplasts of plant cells
as insoluble granules composed of a-amylose (nor-
mally 20–30%) and amylopectin (normally 70–80%;
Morrison & Karkalas 1990). a-Amylose is a linear
polymer of several thousands of glucose residues linked
by a(1/4) bonds. Amylopectin, consisting mainly of
a(1/4)-linked glucose residues, is a branched molecule
with a(1/6) branch points at every 24–30 glucose
residues in average (table 1). Amylopectin molecules
contain up to 106 glucose residues, making them some of
the largest molecules in nature (Voet et al. 1999).
Cellulose, the primary structural component of plant
cell walls, is a linear polysaccharide of D-glucose units
linked by b(1/4) glycosidic bonds (table 1). The fully
equatorial conformation of b-linked glucose residues
stabilizes the chair structure, minimizing its ﬂexibility.
This highly cohesive, hydrogen-bonded structure gives
cellulose ﬁbres the exceptional strength and makes
them water insoluble despite their hydrophilicity (Voet
et al. 1999). Cellulosic materials exhibit, however, poor
degradation in vivo (Entcheva et al. 2004).
2.3.2. Exudate gums. Exudate gum polysaccharides are
produced at the surface of a plant, usually as a result of
trauma or stress (physical injury and/or fungal attack).
These exudates are complex, uronic acid-containing
polysaccharides; some are even associated with proteins
(Stephen et al. 1990). Most gums are soluble in water
and have high viscosity. Major use of gums is in the
food and pharmaceutical industries, where their emul-
sifying, stabilizing, thickening and gel-forming proper-
ties are the main physical requirements (Stephen et al.
1990). The gums with major commercial value are gum
arabic, larch gum, gum karaya, gum ghatti and gum
tragacanth (Stephen et al. 1990). Arabinogalactan is a
major D-galactan obtained from soft woods such as
larch (larch gum). It is composed of b(1/3)-linked
D-galactose units, each containing a side chain at
position C6. It is extracted from the Larix tree and
available in 99.9% pure form with reproducible
molecular weight and physico-chemical properties. The
high solubility in water, biocompatibility, biodegrad-
ability and the ease of chemical modiﬁcation in aqueous
media make it an attractive polymer for the synthesis of
scaffolds for application in tissue engineering.
Gum arabic is an exudate gum obtained from Acacia
trees and consists of a variable mixture of arabinogalac-
tan oligosaccharides, polysaccharides and glycoproteins.
It is an acidic arabinogalactan with a complex structure.
The main chain of this polysaccharide consists of
b(1/3) and b(1/6)-linked D-galactose units along
with b(1/6)-linked D-glucopyranosyl uronic acid units.
Though gum arabic has high water solubility (up to
50% w/v) and relatively low viscosity (Izydorczyk et al.
2005), it exhibits emulsiﬁcation, encapsulation and ﬁlm-
forming abilities.
2.3.3. Algal polysaccharides. Alginate, the monovalent
form of alginic acid, is a linear polymer of b(1/4)-
linked D-mannuronic acid and a(1/4)-linked
L-guluronic acid, which occurs combined with calcium
and other bases in the cell walls and intracellular
matrix of brown seaweeds, constituting the main
structural component (Percival & McDowell 1990).
The residues are present in the blocks of each monomer,
separated by regions in which they are randomly
arranged or alternating. The proportions of mannuro-
nic (M) and guluronic (G) residues (table 1), and the
lengths of the blocks, can vary considerably, depending
on the source of the alginate. The polymer undergoes
ionotropic gelation in the presence of divalent cations
and gelling depends on the ion binding (Mg2C/
Ca2C!Sr2C!Ba2C; Izydorczyk et al. 2005). One of the
drawbacks of alginate hydrogels is that the degradation
occurs via a slow and unpredictable dissolution process
in vivo (Rowley et al. 1999; Bouhadir et al. 2001;
Boontheekul et al. 2005).
Galactans, the major polysaccharides of the red
algae Rhodophyceae, comprise agars, carrageenans
and related hybrid polysaccharides. Agar is made of
two components: agarose (a non-sulphated fraction)
and agaropectin (a mixture of various sulphated
molecules). The separation of agarose from the
polysaccharide mixture is based on the differences in
solubility and chemical reactivity, which is associated
with the anionic character of agaropectins (Percival &
McDowell 1990). Agarose is a linear polysaccharide
based on the (1/3)-b-D-galactopyranose-(1/4)-3,6-
anhydro-a-L-galactopyranose unit (table 1). This
arrangement allows the chains to join together and
adopt a double helix. The two chains are wrapped
together so tightly that any gaps are closed, trapping
any water inside the helix.
Carrageenan polysaccharides are linear polymers
consisting of chains of (1/3)-linked b-D-galactose and
(1/4)-linked a-D-galactose units, which are variously
substituted and modiﬁed into the 3,6-anhydro deriva-
tive, depending on the source and extraction conditions
(table 1; Thanh et al. 2002). All carrageenans are highly
ﬂexible molecules, which at higher concentrations wind
around each other to form double helical structures.
This gives them the ability to form a variety of different
gels at room temperature. k- and i-carrageenans form
thermoreversible gels on cooling in the presence of
appropriate counterions. A particular advantage is that
they are thixotropic (Bartkowiak & Hunkeler 2001), i.e.
they thin under shear stress and recover their viscosity
once the stress is removed.
2.3.4. Animal polysaccharides. Chitin is the principal
structural component of the exoskeletons of invert-
ebrates, such as crustaceans and insects, and is also
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present in the cell walls of most fungi and many algae.
It is a homopolymer of b(1/4)-linked N-acetyl-D-
glucosamine residues (GlcNAc; Lezica & Quesada-
Allue´ 1990). Chitin can be converted into soluble
derivatives such as chitosan, carboxymethyl chitin and
glycochitin, among others (Kurita 2001).
Chitosan is soluble in diluted acids. The number
fraction (%) of GlcNAc residues in the polymer chain is
designated by degree of acetylation (DA) and inﬂu-
ences the chitosan physico-chemical properties, such as
solubility, reactivity, biodegradability and cell response
(Khor & Lim 2003; Freier et al. 2005a). Water-soluble
derivatives (e.g. carboxymethyl chitin) can also be
obtained, extending the domain of applications of
chitin, especially in the biomedical ﬁeld. Chitin
derivatives possess many unique properties, such as
biocompatibility, biodegradability, hydrophilicity,
adsorption capability and high reactivity. Moreover,
chitin-based polymers are materials with great versa-
tility to be processed in different forms (ﬁbres, sponges,
membranes, beads and hydrogels; Khor & Lim 2003; Di
Martino et al. 2005; Yi et al. 2005).
Glycosaminoglycans are unbranched polysacchar-
ides that consist of alternating uronic acid and
hexosamine residues. The extracellular spaces, in
particular those of connective tissues such as cartilage,
tendon, skin and blood vessel walls, contain collagen
and other proteins embedded in a gel-like matrix that is
composed largely of GAGs.
Hyaluronic acid, also known as hyaluronan or
hyaluronate, is an important GAG component of
connective tissue, synovial ﬂuid (the ﬂuid that
lubricates joints) and the vitreous humour of the eye
(Drury & Mooney 2003). Hyaluronic acid is a linear
polysaccharide composed of 250–25 000 b(1/4)-
linked disaccharide units, which consists of D-glucuronic
acid and N-acetyl-D-glucosamine (GlcNAc) linked by
b(1/3) bond (table 1). The disaccharide units of
hyaluronic acid are extended, forming a rigid
molecule whose numerous repelling anionic groups
bind cations and water molecules. In solution,
hyaluronate occupies a volume approximately 1000
times that in its dry state. Hyaluronate solutions
exhibit clear viscoelastic properties that make them
excellent biological absorbers and lubricants. In
addition, hyaluronic acid can be easily and control-
lably produced in large scales through microbial
fermentation, enabling the scale-up of derived
products and avoiding the risk of animal-derived
pathogens. Chondroitin-4-sulphate and chondroitin-6-
sulphate differ only in the sulphation of their
N-acetylgalactosamine (GalNAc) residues. Dermatan
sulphate is derived from chondroitin by enzymatic
epimerization of C5 of glucuronate residues to form
iduronate residues. Keratan sulphate is the most
heterogeneous of the major GAGs, in that its sulphate
content is variable and contains small amounts of
fucose, mannose, GlcNAc and sialic acid. Heparin also
consists of a variably sulphated repeating disaccharide
unit, with an average of 2.5 sulphate residues per
disaccharideunit,whichmakes it themosthighlycharged
polymer in mammalian tissues.
2.3.5. Microbial polysaccharides. Dextran is a branched
bacterial polysaccharide, produced from sucrose via the
action of dextransucrase enzyme (Naessens et al. 2005),
consisting of a(1/6)-linked D-glucose residues with
some degree of branching via a(1/3) linkages
(table 1). The molecular weight and degree of branch-
ing is dependent on the source of dextrans and may
vary from 0.5 to 60%. Both the degree of branching and
molecular weight distribution affect its physico-
chemical properties (Mehvar 2000).
Gellan gum is a high molecular weight bacterial
exopolysaccharide. It is a linear anionic heteropolysac-
charide composed of the tetrasaccharide (1/4)-L-
rhamnose-a(1/3)-D-glucose-b(1/4)-D-glucuronic
acid-b(1/4)-D-glucose as a repeating unit (table 1). In
its native, or high acyl form, two acyl substituents
D-acetate and D-glycerate are present. Both sub-
stituents are located in the same glucose residue. The
high acyl form produces transparent, soft, elastic and
ﬂexible gels that are resistant to heat and acid, whereas
the low acyl form produces ﬁrm, non-elastic brittle gels.
Gel formation is due to a conformational heat reversible
transition from a state of single random macro-
molecules to a more ordered state, where macro-
molecules pair with each other to form double helices
(Cascone et al. 2001).
Pullulan is an extracellular microbial homopolysac-
charide of glucose, produced from starch by fermenta-
tion, and consists in repeating units of maltotriose
(a(1/4)-linked) joined by a(1/6) linkages (table 1).
Some advantages of pullulan are its non-toxicity and
lack of immunogenicity (Gupta & Gupta 2004).
Xanthan gum is an anionic polysaccharide produced
from glucose via fermentation by the bacterium
Xanthomonas campestris (Rosalam & England 2006).
The structure of xanthan is based on a cellulosic
backbone of b(1/4)-linked glucose units that have
trisaccharide side chains of D-mannose-b(1/4)-D-
glucuronic acid-b(1/2)-D-mannose linked to C3
every second glucose unit in the main chain. Some
terminal mannose units can contain a pyruvate group
and mannose residues attached to backbone units are
variably acetylated. It has unique rheological proper-
ties (high viscosity even at low concentrations) and
forms hydrogels by annealing the solution in sol state
and subsequent cooling (Iseki et al. 2001).
Cellulose can be produced by the bacterium
Gluconacetobacter xylinus (table 1). Bacterial cellulose
(BC) has unique properties, including biocompatibility,
high water-holding capacity, high crystallinity, a ﬁne
ﬁbre network and high tensile strength in the wet state.
In addition to its cost-efﬁcient and relatively simple
production, it has the advantage of in situmouldability
(Svensson et al. 2005).
Table 1 summarizes the polysaccharides that are
currently used in the ﬁeld of tissue engineering and
regenerative medicine. However, there is a wide variety
of other potentially useful polysaccharides exhibiting a
diversity of structures and functions (e.g. pseudoplastic
behaviour, gelation, water binding, etc.), such as
laminarin, gluco- and galactomannans, exudate and
mucilage gums, xanthan gum, levan, curdlan, among
many others, which remain unexploited within the
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biomedical ﬁeld. This situation may be associated
with their current unavailability, difﬁculty of their
isolation/puriﬁcation and processing and/or lack
of information related to their biocompatibility
and toxicity.
An important aspect to consider when using natural
materials is that they can induce an undesirable
immune response due to the presence of impurities
and endotoxins, depending on the source of the
material. Additionally, their properties may differ
from batch to batch during large-scale isolation
procedures due to inability to control the processing
techniques. Nevertheless, as knowledge about these
natural materials is widening, new approaches, includ-
ing methods for production, puriﬁcation, control of
material properties (mechanical and degradation rate)
and for enhancing material biocompatibility, are being
developed for designing better scaffolding materials
to support the development of more natural and
functional tissues.
2.4. Naturally derived polyesters
Polyhydroxyalkanoates (PHAs) are degradable, bio-
compatible, thermoplastic polyesters derived from
micro-organisms, used as a reserve of carbon and
energy. A great variety of materials of this family can
be produced, but the use of PHAs in tissue engineering
has been mainly restricted to two polymers, namely
poly(hydroxybutyrate), PHB, and poly(hydroxybuty-
rate-co-valerate), PHBV (Williams et al. 1999; Chen &
Wu 2005); the copolymerization produces less crystal-
line, more ﬂexible and more readily processable
materials than pure PHB. Previous works have shown
that such materials can be used as cell support for tissue
engineering application (e.g. Deng et al. 2002).
3. PROCESSING OF TISSUE ENGINEERING
SCAFFOLDS
Successful tissue engineering strategies require the
development of an adequate scaffold that supports the
regeneration process. The scaffold provides a three-
dimensional structure and template upon which the
tissue-speciﬁc cells attach, proliferate and produce
ECM. The scaffold should provide sufﬁcient surface
area for the initial cell seeding and subsequent
proliferation and colonization of the construct.
Furthermore, the necessary diffusion of nutrients and
metabolites in a three-dimensional environment
demands highly porous scaffolds (Karageorgiou &
Kaplan 2005). Ideally, the material should degrade in
agreement with the deposition of ECM.
3.1. Particle leaching
Particle leaching is one of the most widely used
processing methods to obtain controlled size of the
porosity of scaffolds (Riddle & Mooney 2004). The
process is based on the dispersion of a porogen agent
(such as salt, sugar or others) either in a liquid,
particulate or powder-based material (Hou et al. 2003;
Lee et al. 2004c). The liquid may be solidiﬁed by solvent
evaporation, crosslinking or other reactions, and the
powder may be compacted using pressure and tempera-
ture. After the shaping process, the porogen agent is
dissolved by immersion in a solvent speciﬁc to it and
porosity is created (Lee et al. 2003). Besides the uneven
permeability caused by the poor dispersion of the
porogen, it is relevant to highlight its adverse effect
over the mechanical properties of the porous structure
(Zhang et al. 2005). Advantages of this process include
its simplicity, versatility and easiness of control of the
pore size and geometry. The pore geometry is obtained
by the selection of the shape of the porogen agent,
whereas the pore size is controlled by sieving the
porogen particles to a speciﬁc dimension range. It is,
however, difﬁcult by this method to accurately design
the interconnectivity of the pores (Moore et al. 2004).
3.2. Freeze drying
Freeze drying is a commonly used process to stabilize
and preserve heat-sensitive bioproducts. The method is
based on the formation of ice crystals that induce
porosity through ice sublimation and desorption. The
kinetics of the freezing stage controls the porosity and
the interconnectivity of foams (Liapis et al. 1996). It is
possible to control the porosity level of the foams by
varying the freezing time and the annealing stage
(Hottot et al. 2004). Values of porosity up to 90% with
different interconnectivities are common in freeze-dried
structures. The main difﬁculty associated with this
process is to ensure structural stability and adequate
mechanical properties of the porous constructs after
subsequent hydration. This limitation hinders its use
when the application involves conditions with mechan-
ical stress, even at low-to-moderate levels. Our group
developed bioactive chitosan/hydroxyapatite scaffolds
using this method (Malafaya & Reis 2003). Another
study (Oliveira et al. 2006) developed bilayered
scaffolds based on chitosan and hydroxyapatite aimed
at osteochondral application, where the porous
morphology of the chitosan layer was induced by
freeze drying.
3.3. Phase separation
Phase separation of polymeric solutions can be induced
by various techniques. An extensive review of the
processes available has been published elsewhere
(vandeWitte et al. 1996). Thermal-induced phase
separation is based on the decrease in solubility
associated with temperature increase. After demixing
is induced, the solvent is removed by extraction,
evaporation or freeze drying (Yang et al. 2004). In
air-casting precipitation, a polymer solution is prepared
by dissolving a polymer in a mixture of a volatile
solvent and a less volatile non-solvent. Upon evapora-
tion of the solvent, the solubility of the polymer
decreases and the phase separation takes place
(Zeman & Fraser 1993). Immersion precipitation is
the casting of a polymer solution as a thin ﬁlm on a
support or by extruding the solution through a die
followed by subsequent immersion in a non-solvent
bath (Cheng et al. 1995).
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Several natural-based biodegradable polymers and
composites have been processed by this route, including
chitosan/nano-hydroxyapatite (Almany & Seliktar
2005), chitosan-gelatine/hydroxyapatite (Zhao et al.
2002) and alginate/hydroxyapatite (Lin & Yen
2004) composites.
3.4. Fibre meshes and ﬁbre bonding
Fibre meshes produced from melt- or solution-spun
ﬁbres have also been investigated as TE scaffolds. Our
group has developed starch-based scaffolds (Gomes
et al. 2003; Pavlov et al. 2004) by melt-spinning blends
of starch with ethylene vinyl alcohol copolymer,
poly(3-caprolactone) (PCL) and polylactide (PLA)
into ﬁbre bundles. In this methodology, ﬁbre mesh
scaffolds are produced by applying a heat treatment to
bond ﬁbre bundles (Pavlov et al. 2004). For these
scaffolds, cell survival was shown to be highly depen-
dent on scaffold porosity, which is believed to be related
to the more efﬁcient diffusion of nutrients within the
scaffold (Gomes et al. 2004a). Our group has yet
proposed another method for the production of ﬁbre
mesh scaffolds from non-fusible materials, by directly
producing ﬁbre bundles by wet spinning (Tuzlakoglu
et al. 2004).
3.5. Melt processing
The non-thermoplastic behaviour of natural polymers
has limited the application of melt-based processing
methods for the production of TE scaffolds to these
materials. However, several melt-based processing
methodologies, such as compression moulding com-
bined with particulate leaching, extrusion and injection
moulding with blowing agents, have been proposed
within our group. Foaming during melt extrusion or
injection moulding is based on the use of physical or
chemical blowing agents that are responsible for
inducing porosity. Research on these processing routes
has mainly been focused on the use of chemical blowing
agents. So far, TE scaffolds based on thermoplastic
blends of starch with ethylene vinyl alcohol copolymer
and cellulose acetate have been produced by melt
extrusion, employing endothermic chemical blowing
agents based on mixtures of citric acid and sodium
bicarbonate (Gomes et al. 2002). These scaffolds have
been reported to be highly biocompatible (Salgado et al.
2002) and to exhibit adequate properties, both in terms
of porosity and pore geometry, for supporting cell
growth and apparent bone formation (Salgado et al.
2004b). A similar strategy has been applied for the
production of TE scaffolds based on injection moulding
(Gomes et al. 2001; Neves et al. 2005). Compared with
extrusion, injection moulding uses the combined effect
of heat and shear to plasticize thermoplastic formu-
lations. More recently, physical blowing agents such as
supercritical CO2 and water have been used to produce
TE scaffolds by injection moulding (Haugen et al. 2005;
Leicher et al. 2005).
3.6. Batch foaming
Traditional methods for the production of microporous
materials are based on phase separation of a homo-
geneous polymer solution by temperature quench or by
the addition of an anti-solvent. Alternatively, it is
possible to produce porous morphologies by ﬁrst
saturating a polymer with a high pressure or super-
critical gas (usually CO2) at controlled temperature
and submitting it to pressure quenching induced by
rapid depressurization. The production of TE scaffolds
by batch foaming is based on the saturation of a
polymer with pressurized gas, followed by a rapid
pressure reduction that causes thermodynamic instabil-
ity and subsequent nucleation and growth of gas pores.
Mooney and co-workers (Harris et al. 1997, 1998)
pioneered the use of this strategy for the development of
TE scaffolds based on PLA, PGA and poly(lactic-co-
glycolic acid) (PLGA) in combination with particle salt
leaching. Recently, anisotropic composites based on
PLA and hydroxyapatite (HA) were produced
(Mathieu et al. 2005, 2006) by a different method
based on the saturation of the polymer above its
melting temperature with supercritical CO2 followed
by rapid depressurization, which resulted in porosity
levels up to 87.8% (Mathieu et al. 2006). As opposed to
the use of high pressure or supercritical, other foaming
methods have also been investigated, which rely on the
use of chemical foaming agents. Silk ﬁbroin scaffolds
were developed using ammonium bicarbonate as a
porogen agent (Nazarov et al. 2004). In this case, a
solution of silk ﬁbroin solution containing ammonium
bicarbonate was dried and stabilized with ethanol,
before being foamed in hot water. An alternative batch
foaming method for the production of scaffolds is based
on the supersaturation of a polymer paste containing
sodium bicarbonate salt particles with citric acid (Jun
Jin & Park 2001). This methodology has been applied
to the fabrication of galactose-conjugated PLGA
scaffolds (Tae Gwan 2002) and PLGA scaffolds
incorporating dexamethasone (Yoon et al. 2003).
3.7. Electrospinning
Electrospinning (or electrostatic spinning) can be used
to produce polymeric nanoﬁbre non-woven membranes.
The process is controlled by a high intensity electric
ﬁeld created between two electrodes bearing electric
charges of opposite polarity. One electrode is placed in
the polymer solution and the other is placed in the
collector. The polymer solution is pumped from a
needle forming a drop of solution. When the electric
ﬁeld produces a force in the droplet that is able to
overcome the surface tension of the solution, a jet of
polymer is ejected, producing the ﬁbres. The solvent
starts to evaporate at the instant of jet formation and
continues after the nanoﬁbres are deposited in the
collector. The characteristics of the nanoﬁbres and
meshes depend on various properties of the solution and
on the processing parameters. This process gained a
renewed interest in the early 1990s for the development
of nanostructured membranes aimed at biomedical
applications. Most of the work in this ﬁeld uses
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biodegradable synthetic polymers (such as PLLA and
PCL) to produce non-woven membranes for various
tissue engineering or drug delivery applications (Li &
Xia 2004). Extensive reviews of the electrospinning
process can be found elsewhere (Reneker & Chun
1996). Different modiﬁcations of the process have been
proposed in order to produce non-woven meshes or
ﬁbres with speciﬁc tailored morphologies, such as
hollow ﬁbres (Yu et al. 2004), aligned nanoﬁbres
(Li et al. 2004; Xu et al. 2004) or continuous nanoﬁbre
yarns (Ko et al. 2003).
3.8. Rapid prototyping
The difﬁculties and limitations of the previous proces-
sing routes have led to the investigation of alternative
processing methodologies based on solid freeform
fabrication (SFF) or rapid prototyping (RP). One of
the main advantages of the latter is the possible
integration of RP fabrication with computer-assisted
design and medical imaging acquisition and processing
techniques for the production of anatomically adapted
scaffolds, featuring customized internal architectures.
Although the integration of the previously mentioned
technologies for the production of TE scaffolds is not
exactly novel, only recently a common designation has
been proposed: computer-assisted tissue engineering
(Sun & Lal 2002; Sun et al. 2004a,b; Tuan & Hutmacher
2005; Wettergreen et al. 2005).
In this area, great emphasis has been given to the
development of TE scaffolds by extrusion-based RP.
In techniques such as fused deposition modelling
(FDM), a ﬁlament of material is heated up and
melted in an extrusion nozzle and deposited layer by
layer, according to a programmable path. The
temperature and ﬂow of the material is controlled
by an extrusion head, while the scaffold construction
in the Z-axis is ensured by the relative movement of
the platform to the extrusion head. Hutmacher and
co-workers (Hutmacher et al. 2001; Schantz et al.
2002, 2005; Zein et al. 2002) have reported the
development of TE scaffolds using the FDM of PCL.
In the so-called three-dimensional deposition process,
also referred to as three-dimensional bioplotting, the
material in the powder or granular form is heated
inside a barrel and the molten material is displaced
by a plunger or piston, while in precise extrusion, the
plasticization of the melt is made by a rotating screw.
Our group has been developing TE scaffolds based on
thermoplastic blends of starch using this approach.
Figure 1 presents, as an example, a scaffold geometry
based on starch/PCL blend, featuring an orientation
pattern between consecutive layers of 08/908, a ﬁbre
thickness of 0.5 mm, a spacing between ﬁbres of 2.0 mm
(in the same layer) and an offset ﬁbre distance (between
consecutive layers) of 1.0 mm. Selective laser sintering
has also been used to process natural-based polymer
scaffolds. In this technique, each layer of the scaffold is
built by scanning and sintering of a powdered substrate
by a laser beam.
The non-fusible behaviour of many natural-based
polymers limits the application of SFF techniques
based on melting. Three-dimensional printing is an
alternative RP fabrication of scaffolds, which uses
starch as a binder (Kim et al. 1998; Lam et al. 2002;
Pﬁster et al. 2004; Seitz et al. 2005). Three-dimensional
printing is based on the selective bonding of powder
particles via the deposition of a binder resin. Solid
freeform fabrication techniques have also focused on
the processing of non-fusible natural polymers, such as
chitosan and chitosan/hydroxyapatite composites
(Ang et al. 2002; Geng et al. 2005). In this approach,
the scaffold is built layer by layer through the
dispensing of a chitosan/acetic acid solution into
sodium hydroxide-based media that causes the neutral-
ization of the acetic acid and the formation of a gel-like
chitosan strand. Figure 2 shows chitosan scaffolds being
built by three-dimensional bioplotting in our research
group, where the reproducibility of the chitosan pattern
is evident. The use of low temperature in this processing
method enables, in principle, the encapsulation of cells
and bioactive molecules, which is not possible in melt-
based processes. An example of this is the development
of gelatin/alginate scaffolds encapsulating cells (Yan
et al. 2005a,b) produced by the consecutive deposition
of a mixture of gelatin/alginate and hepatocytes cells,
using a microdispenser and subsequent crosslinking by
calcium chloride or glutaraldehyde. Other studies
(Campbell et al. 2005; Weiss et al. 2005) focused on
the scaffold fabrication by inkjet printing of ﬁbrin
hydrogen printing incorporating ﬁbroblast growth
factor 2 (FGF-2) and bone morphogenetic protein 2
(BMP-2). Hydroxyapatite-based scaffolds have also
been developed (Wang et al. 2002b) by the so-called
three-dimensional gel lamination system, in which
gelling of sodium alginate and calcium chloride was
used to gel a hydroxyapatite slurry. An alternative
method is to use RP technologies to manufacture a
sacriﬁce mould based on which scaffolds are produced
(Sachlos et al. 2003).
4. MICROSPHERE-BASED STRATEGIES
APPLIED TO TISSUE ENGINEERING
The ‘traditional’ drug delivery approach can be applied
in the context of TE when strategies include the
encapsulation of growth factors or living cells within
the scaffolds. In turn, scaffolds can be designed as
traditional drug delivery carriers to control a site- and
time-speciﬁc release proﬁle and also to protect the
growth factor (Malafaya et al. 2002). Having this
strategy in mind, one can understand the role of
microsphere-based technology in tissue engineering
applications. Microspheres have been used in the ﬁeld
of tissue engineering mainly to encapsulate growth
factors or cells. But microspheres can also be used as
injectable scaffolds to support cell growth and prolifer-
ation directly or can be aggregated by these cells in
order to form living tissue-engineered constructs.
Furthermore, the aggregation of the microspheres
themselves can be used as a processing technique to
produce porous scaffolds. Another approach that has
been usually used is to embed loaded microspheres
(with growth factors or cells) in hydrogels that are then
implanted as an integrated construct. Finally, micro-
spheres can be combined with porous scaffolds by either
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Figure 1. Starch/PCL scaffolds produced by three-dimensional bioplotting as observed in (a) the isometric perspective and
(b) the XX0 building direction, featuring an orientation pattern between consecutive layers of 08/908 and 1 mm offset ﬁbre
distance between consecutive layers.
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direct incorporation within the scaffold, injecting
together when implanted, or more rarely used as a
coating of these scaffolds.
4.1. General considerations on microparticles
Polymer spheres with sizes up to 2 mm are produced by
various processes, including precipitation, spray drying
or suspension, emulsion and dispersion polymerizations
(Tuncel et al. 1996; ODonnell &McGinity 1997). These
include microcapsules and vesicular systems in which a
cavity is surrounded by a unique polymeric membrane
and microspheres, which are matrix-ﬁlled systems
(Couvreur & Puisieux 1993).
If they are aimed to be used as drug delivery systems
and are fabricated as microspheres, they can be injected
with a syringe (Eliaz & Kost 2000; Tinsley-Bown et al.
2000) or administrated intranasally as dry powder
(Tinsley-Bown et al. 2000), and therefore surgical
implant is avoided. In the case of bone and cartilage
tissue engineering, they can be injected or combined
with the scaffold used for implantation on the repair
site, as well as can serve as substrates for cells of
interest. In the latter, they can serve either as part of an
in vitro strategy or an in vivo vehicle.
4.2. Cell–microparticle constructs
Cell culture techniques have become vital for the study of
animal cell structure, function and differentiation and for
the production of many important biological materials,
such as vaccines, enzymes, hormones, antibodies, inter-
ferons and nucleic acids. Microcarrier culture makes
possible the practical high-yielding culture of anchorage-
dependent cells. In microcarrier culture, cells grow as
monolayers on the surface of small spheres, which are
usually suspended in culture medium by gentle stirring.
Cells cultured on microcarriers are often used as
substrates for the production of viruses or cell products
and the microcarrier method is compatible with
standard production procedures.
These principles were extrapolated to tissue engin-
eering, where these systems might be used both as a
strategy for cell expansion and as components of
constructs containing materials and cells. An example
of such extrapolation is found in Qiu et al. (1998, 2001),
where the authors were able to create bone tissue
engineering construct using rat marrow stromal cul-
tures and microcarriers in a high aspect rotating vessel
(HARV) bioreactor.
This approach holds great potential for tissue
engineering applications, and the challenge remains in
designing the appropriate microcarriers that suit the
needs of the system. Microspheres have also been used
as injectable scaffolds for tissue engineering. In this
way, it is expected that easy ﬁlling of irregularly shaped
defects can be done through minimally invasive surgical
procedures. One can easily identify two different
approaches: one where microspheres can be injected
immediately mixed with cells (Kang et al. 2005) and
another where microspheres can serve as a carrier for
in vitro cell attachment and are injected at a later stage
(Senuma et al. 2000; Newman & McBurney 2004). An
interesting study (Curran et al. 2005) refers to the use of
TGF-b1-loaded microspheres as microcarriers for
chondrocytes expansion and ECM formation in a
bioreactor that can be applied in cartilage tissue
engineering as injectable system or as integral con-
struct, depending on the formation (or not) and size of
aggregates of chondrocytes-seeded microspheres.
Another strategy based on microsphere-based tech-
nology is the production of porous scaffolds based on the
chemical, thermal or physical agglomeration of micro-
spheres. A novel processing route based on chitosan
particle aggregation was already described for the
production of cartilage and osteochondral tissue
engineering scaffolds (Malafaya et al. 2005), where
bilayered scaffolds were developed using the particle
aggregation (Malafaya et al. 2005). The group of
(a) (b)
Figure 2. (a) Chitosan scaffold being built by three-dimensional bioplotting by our group and (b) its pattern as observed by stereo
light microscopy. The distance between ﬁbre strands is 1 mm.
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C. T. Laurencin (Devin et al. 1996; Ambrosio et al.
2001; Borden et al. 2002a,b, 2003; Khan et al. 2004) has
been applying this technique for the development of
microsphere-based matrices for bone repair. The
researchers have tried different approaches by devel-
oping sintered microsphere-based matrices (Borden
et al. 2002b, 2003) or gel microsphere-based matrices
(Borden et al. 2002a). Composite microspheres
containing hydroxyapatite were also used for the
fabrication of polymer–ceramics three-dimensional
matrices for bone applications (Devin et al. 1996;
Ambrosio et al. 2001; Khan et al. 2004). Heating the
pre-fabricated microspheres above the glass transition
temperature further processes the three-dimensional
structures, as a means of forming contacts between
neighbouring microspheres (Borden et al. 2002a). In the
gel microsphere-based matrix approach, the gel micro-
spheres are previously obtained by emulsion with
poly(vinyl alcohol) (PVA; Borden et al. 2002a). The
ensuite aggregation process is based on multiple steps,
including air drying, freeze drying, rehydration with salt
leaching and new freeze drying. In general, microsphere-
based matrices show very interesting properties for a
possible application in bone repair. Recently, the same
group has been working with blends of chitosan/PLGA
(Jiang&Laurencin 2005) to take advantage of chitosan’s
great ﬂexibility in chemical modiﬁcations within its
amino and hydroxyl groups.
These three-dimensional structures based on micro-
particles can also serve as vehicles for the delivery of
biologically active factors (e.g. growth, differentiation
factors or DNA) in order to manipulate cellular
processes occurring within the scaffold microenviron-
ment. Nof et al. (Nof & Shea 2002) have developed
DNA-loaded microspheres that were subsequently
aggregated into an interconnected open-pore scaffold
(above 94% porosity) via a gas-foaming/particulate
leaching process.
Another widely used strategy is based on the
incorporation of microspheres into hydrogels. Ideally,
these combined systems allow greater control over
protein activity and stability when compared with
proteins incorporated directly into the matrix (which is
often associated with a fast release even if covalently
linked), and also provide advantages over methods
relying on ‘ﬁne tuning’ of the hydrogel structure and
diffusivity. A tissue engineering strategy for adipose
tissue uses gelatin microspheres incorporating basic
ﬁbroblast growth factor (bFGF) that are integrated
into an extract of basement membrane protein
(Matrigel) (Tabata et al. 2000; Kimura et al. 2002).
This strategy aimed at increasing the development of a
vascular supply, essential for generation and mainten-
ance of the adipose tissue, as well as for other main
living tissues such as bone. Furthermore, this work
(Kimura et al. 2002) concludes that gelatin micro-
spheres incorporating bFGF enable Matrigel to efﬁ-
ciently induce de novo adipogenesis at the implanted
site in respect of the formation rate and volume of
adipose tissue when compared with the controls.
Leach et al. (Leach & Schmidt 2005) have developed
a combined system composed of BSA-loaded micro-
spheres incorporated into a photopolymerizable
hyaluronic acid-based hydrogel. Another example is
the combination of microspheres containing TGF-b1
(DeFail et al. 2006) or TGF-b1 together with micro-
spheres containing IGF-1 (Elisseeff et al. 2001), which
have been incorporated into PEO-based hydrogels with
or without chondrocytes encapsulated for cartilage
tissue engineering applications.
Another strategy presented by the group of Mikos
(Payne et al. 2002a–c) is to use gelatin microspheres as
microcarriers for marrow stromal cells (Payne et al.
2002c) that are further incorporated into injectable
polymeric scaffolds (Payne et al. 2002a,b). The results
suggest that temporary encapsulation of cells in cross-
linkedgelatinmicroparticlesmaypreserve the viability of
cells, creating the possibility of using these as part of an
injectable hydrogel scaffold for bone tissue engineering
applications aimed at minimally invasive procedures.
Finally, microspheres can be combined with porous
scaffolds by either direct incorporation within the
scaffold or injecting together when implanted. The
study of Isogai et al. (2005) clearly demonstrates that
the impregnation of the loaded microspheres into the
scaffolds is much more effective when compared with
the simultaneous injection of the loaded microspheres.
Other studies may be found in the literature where
gelatin microspheres are combined with collagen
sponges for different applications, such as periodontal
tissue regeneration (Nakahara et al. 2003) or adipose
tissue engineering (Kimura et al. 2003).
A common concern for tissue engineering of different
living tissues is the vascularization. Site-speciﬁc delivery
of angiogenic growth factors from tissue-engineered
devices should provide an efﬁcient means of stimulating
localized vessel recruitment to the cell transplants and
would ensure cell survival and function. Obviously, the
microsphere-based technology seems to be ideal to induce
this complementary vascularization in tissue-engineered
constructs. An example is given by Perets et al. (2003)
where bFGF-loaded microspheres are incorporated into
alginate porous scaffolds to enhance vascularization after
implantation in rat peritoneum.The number of penetrat-
ing capillaries into the bFGF releasing scaffolds was
nearly fourfold higher than that into the control scaffolds
(Perets et al. 2003). Furthermore, the released bFGF
induced the formation of large andmatured blood vessels,
as judged by the massive layer of mural cells surrounding
the endothelial cells (Perets et al. 2003).
For cartilage tissue engineering, studies that use
microsphere-based technologies have mainly focused on
the use of chitosan-based systems. Kim et al. (2003)
have designed a type of porous chitosan scaffold,
containing TGF-b1, to enhance chondrogenesis. It
was demonstrated that the scaffold containing the
loaded chitosan microspheres signiﬁcantly increased
the cell proliferation and production of ECM. A similar
approach using chitosan-based materials was reported
by Lee et al. (2004a), where a three-dimensional
collagen/chitosan/glycosaminoglycan scaffold was
seeded with rabbit chondrocytes and combined with
TGF-b1-loaded chitosan microspheres. This set-up
allowed for evaluating the effect of released TGF-b1
on the chondrogenic potential of rabbit chondrocytes in
such combined systems. It was observed that both
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the proliferation rate and GAG production were
signiﬁcantly higher in the TGF-b1 microsphere-
incorporated scaffolds than in the control scaffolds
without microspheres.
To summarize, the described combined systems using
microsphere-based technologies seem to be suitable for
delivering cells or agents, such as growth factors, in
scaffolding for tissue engineering applications of living
tissue regeneration such as for bone and cartilage.
5. MEMBRANES AS WOUND DRESSING
Skin is a very heterogeneous membrane and its primary
function is to serve as protective barrier against the
external environment. The ability of the skin to repair
itself after a minor wound is remarkable, but when the
damage is severe or occurs in large amounts of skin
area, proper and immediate coverage of the wound
surface with an adequate dressing is needed to
protect and accelerate wound healing (Bradley et al.
1999; Clark & Singer 2000). Ultimately, the immediate
wound coverage, permanent or temporary, is one of the
principal goals of wound management (Clark & Singer
2000). Ideally, autologous human skin is considered as
the ‘gold standard’ for treatment of skin wounds.
However, skin grafts are not always the perfect
solution. They are limited with respect to the con-
ditions needed for tissue availability, graft rejections
and conformability with the surrounding tissue with
respect to thickness and pigmentation (Bradley et al.
1999; Clark & Singer 2000; Young & Parenteau 2002).
Considering tissue engineering and wound repair,
several approaches involving the use of growth factors,
matrix materials, epidermal sheets, dermal replace-
ments and complex skin substitutes have been
described (Clark & Singer 2000; Bello et al. 2001;
Bakos & Koller 2002; Jones et al. 2002; Young &
Parenteau 2002; Horch et al. 2005). Most of the
commercial bioengineered skin devices consist of a
combination of sheets of biomaterial matrix (e.g.
collagen, hyaluronic acid) containing cultured cells
(Bello et al. 2001; Jones et al. 2002; Horch et al. 2005).
Several kinds of temporary dressings have been
designed to provide a bacterial barrier, to control pain
and contribute to an adequate environment for
epithelial regeneration. Based on their nature of action,
wound dressings are generally classiﬁed as passive,
interactive and bioactive products (Bradley et al. 1999;
Paul & Sharma 2004). Traditional wound dressings
such as gauze, knitted viscose dressings and tulle
dressings are passive devices that protect the wound
from further injury, while wound healing takes place
beneath naturally. However, these wound dressings
may adhere to the wound, promoting the patient’s pain
and trauma. Interactive products include polymeric
ﬁlms, hyaluronic products, hydrocolloids and hydro-
gels, which can alter the local wound environment.
Even with advancements in wound dressings, there
is no single dressing suitable for all types of wounds, and
often, different types are needed to be used during the
healing of a single wound (Bradley et al. 1999).
Currently, a variety of natural polymer-based mem-
branes obtained from chitin (Yusof et al. 2003, 2004;
Kumar et al. 2004; Tanodekaew et al. 2004; Muzzarelli
et al. 2005), chitosan (Khan et al. 2000; Wang et al.
2002a; Khan & Peh 2003; Azad et al. 2004; Kumar et al.
2004; Marreco et al. 2004; Paul & Sharma 2004; Wu
et al. 2004; Campos et al. 2005; Wongpanit et al. 2005),
alginate (Wang et al. 2002a), cellulose (Wu et al. 2004;
Czaja et al. 2006), hyaluronic acid (RuizCardona et al.
1996), gelatin (Chang et al. 2003b; Tanaka et al. 2005),
collagen (Grzybowski et al. 1997; Lee et al. 2002; Wu
et al. 2003; Sripriya et al. 2004) and their derivatives
have been developed, in an attempt to supply the high
demand for new materials for skin repair, wound cover
or dressings in the treatment of different wounds.
Researchers have focused on bilayered membranes
for wound dressing, with incorporation of antibiotics
into these matrices for preventing infections. These
types of bilayer wound dressings are composed of dense
top layer and underlying porous sponge-like layer. The
external layer protects the wound and serves as an
artiﬁcial epidermis, while the inner layer is designed for
the drainage of wound exudates and attachment of
wound tissues (Grzybowski et al. 1997; Mi et al. 2001,
2002, 2003; Lee et al. 2002; Sripriya et al. 2004). Mi et al.
(2002, 2003) reported the incorporation of silver
sulphadiazine (AgSD) into asymmetric chitosan. The
results indicate that AgSD-incorporated bilayer chit-
osan wound dressing may be effective in the treatment
of infected wounds.
Current strategies for tissue regenerative wound
dressings have also aimed at the development of
implantable matrices that mimic the natural tissue.
In this context, natural proteins such as collagen
(Grzybowski et al. 1997; Lee et al. 2002; Ruszczak
2003; Wu et al. 2003; Sripriya et al. 2004), gelatin
(Chang et al. 2003b), soy protein (Silva et al. 2003,
2005b), casein (Silva et al. 2003) and silk ﬁbroin (Santin
et al. 1999) have been studied separately or as
composite materials in a template to be used in skin
tissue engineering due to their similarity with the living
tissues. An important issue for the treatment of an
infected wound is to sustain sufﬁcient drug concen-
tration at the site of infection. Therefore, different types
of medicated collagen dressings with antibiotics were
developed (Lee et al. 2002; Sripriya et al. 2004). Lee
et al. (2002) have developed an infection-preventing
bilayered membrane by combining silver sulphadiazine
and a laminin-modiﬁed collagen membrane, which was
shown to facilitate the dermal wound healing process. A
similar bilayer wound dressing system that mimics the
natural skin was later reported by Sripriya et al. (2004).
In another approach (Chang et al. 2003b), protein
modiﬁcations such as crosslinking were used for the
improvement of functional properties of gelatin, in order
to solve the problem of its high solubility in aqueous
environments. It was found that the degree of inﬂam-
matory reaction of membranes treated with genipin
(crosslinking agent) was signiﬁcantly less severe than the
one observed for the glutaraldehyde-crosslinked dressing.
Tanaka et al. (2005) reported the in vivo efﬁciency of a
gelatin ﬁlm sheet impregnated with epidermal growth
factor (EGF) for a novel therapeutic device for cutaneous
wound repair.
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Despite signiﬁcant wound care advances, unmet
needs remain. Nevertheless, since many wounds can be
healed with dressings that do nothing more than cover
and protect the wound from infection, biomacromole-
cule-based bilayer dressings could represent a signi-
ﬁcant advance in wound management.
6. ENCAPSULATION AND INJECTABLE
SYSTEMS
6.1. General principles
The principle of bioencapsulation has long been
accepted by the scientiﬁc community (King & Goosen
1993). This concept arose as a consequence of the use of
polymeric microcapsules for the impetus behind the
need for immunoisolation of transplanted cells or small
clusters of tissue, when treating serious and disabling
human conditions. The main goal of encapsulated cell
therapy research is not only to develop a conﬁned
barrier to entrap living xenogeneic or allogeneic cells to
be transplanted, but also to prohibit the entrance of the
hosts’ antibodies and immune cells, and by this means
avoiding immune rejection or the use of immunosup-
pressive drugs (Gentile et al. 1995; Brissova´ et al. 1998;
Li 1998). Additionally, this barrier must also be
selectively permeable to allow the diffusion of oxygen,
supply of nutrients and release of toxic metabolites. In
this context, a suitable material to accomplish the
encapsulation must act as a membrane to provide a
protective environment, while supporting cells to
maintain their function, differentiation and prolifer-
ation (Zielinski & Aebischer 1994). Thus, an important
component of this three-dimensional volume is the
availability of an ECM that allows the anchor of cells or
simply the stabilization of their positioning (Zielinski &
Aebischer 1994; Uludag et al. 2000).
Numerous techniques have been developed for the
immobilization of cells prior to transplantation (Lo´pez
et al. 1997; Uludag et al. 2000; Muralidhar et al. 2001;
Yeo & Park 2004), but this can be achieved by two
basic mechanisms: (i) microencapsulation, which typi-
cally involves the use of spheres with size ranging from
100 to 300 mm in diameter, and (ii) macroencapsula-
tion, where a higher number of cells can be transplanted
inside a chamber, or in one/several relatively large
capsules/hollow ﬁbres of 0.5–6 mm in diameter and
0.5–10 cm in length (Gentile et al. 1995). Another
recent alternative has been the use of injectable,
biodegradable materials, which can be easily formu-
lated with cells and later on, harden in situ. Despite the
advantage of using microcapsules due to the optimal
geometry for diffusive transport (high surface to volume
ratio), the chambers or capsules have attracted a great
deal of attention because they present better mechan-
ical and chemical stability and are easier to implant
(Li 1998; Uludag et al. 2000; Weber et al. 2004). On the
other hand, injectable systems are advantageous when
the site of the injury is difﬁcult to access, the material of
interest cannot be processed by melt- or solvent-based
techniques or because the device is designed to
incorporate active agents that do not withstand such
processing routes.
The main applications of these systems are as drug
delivery carriers, as encapsulation agents for a diversity
of cells, proteins and other bioactive agents, as well as
tissue engineering scaffolds, mainly of soft tissue
(Boesel & Reis 2004; Gomes et al. 2004b; Silva et al.
2005a, submitted).
The current injectable systems may be divided into
four main classes: (i) thermoplastic pastes (polymers
that can be melted or softened at low temperatures and
injected into the body), (ii) in situ crosslinking/poly-
merizing systems, (iii) in situ precipitation systems
(water-insoluble polymers that are dissolved in a
physiologically compatible solvent and precipitate
upon contact with body ﬂuids), and (iv) injectable
hydrogels, which solidify due to a change in their
environment (pH, temperature, shear, etc.).
Recently, natural-based materials have become the
focus of attention regarding injectable systems. Besides
degradability, they offer the additional advantage of
easier synthesis/preparation and large availability.
Sections 6.2–6.4 will review the most recent
advances in the use of natural-based, degradable
materials as encapsulation and injectable formulations.
6.2. Chitosan
One common alternative for preparing injectable
materials has been by grafting synthetic polymers
with low critical solution temperature (LCST) char-
acter to natural-based polymers. Examples include the
grafting of poly(N-isopropylacrylamide) (PNIPAAm;
Cho et al. 2004; Lee et al. 2004b; Chung et al. 2005a),
Pluronics (Chung et al. 2005a,b) and polyethylene
glycol (PEG; Bhattarai et al. 2005a,b) to a chitosan
backbone.
PNIPAAm is soluble below its LCST, but becomes
insoluble (hydrophobic) above this temperature (Cho
et al. 2004). In PNIPAAm-g-chitosan, the grafting
percentage varied between 9.6 and 712 wt%, and the
polymer presented an LCST of 328C, making it suitable
for biomedical applications (Lee et al. 2004b). The
system was adequate for supporting the culture of
MSCs, allowing their differentiation into chondrocytes
both in vitro (Cho et al. 2004; Chung et al. 2005a) and
in vivo (Cho et al. 2004), and was shown to be non-toxic
and biocompatible (Lee et al. 2004b).
Pluronics is a family of PEO–PPO–PEO triblock
copolymers of ethylene oxide (EO) and propylene
oxide (PO) (Chung et al. 2005b) and some members
are thermoreversible gels. Their graft onto chitosan
yielded a thermosensitive hydrogel, with the transition
temperature of 30–358C when the grafting percentage
was 460–1100 wt% and the solution concentration was
higher than 16% (Chung et al. 2005b).
In the case of PEG, hydrogen bonds between
hydrophilic groups of PEG and water predominate at
low temperature, while hydrophobic interactions
between polymer chains prevail as temperature
increases (Bhattarai et al. 2005b).
Another alternative method to prepare thermally
gelling materials is by chemical modiﬁcation of chitosan
with anhydrides or aldehydes (Ge´rentes et al. 2002).
The physical hydrogel is obtained when the equilibrium
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between polymer/polymer interactions and polymer/
solvent hydrophilic interactions is achieved. For
chitosan, this occurs for a DA of approximately 80%
(Ge´rentes et al. 2002).
Neutralization of acidic chitosan solutions with
glycerol phosphate (GP) allowed the production of a
thermally gelling solution (C–GP) at approximately
neutral pHs (6.8–7.2) (Chenite et al. 2000, 2001). The
most important interactions responsible for this ther-
mal sol–gel transition are the chitosan–chitosan hydro-
phobic interactions, enhanced by the structuring action
of glycerol on water. These gels were able to deliver
active bone protein in vivo and lead to de novo cartilage
and bone formation (Chenite et al. 2000). C–GP gels,
when loaded with primary articular chondrocytes,
preserved chondrocyte viability and phenotype, resided
at least for one week in a mobile osteochondral defect
and served as a scaffold to help build new tissue
(Hoemann et al. 2005). To decrease the very fast release
of low molecular weight hydrophilic compounds, lipo-
somes were added to the C–GP solution, allowing a
controlled delivery of at least two weeks while increas-
ing the gelation rate and gel strength (Ruel-Garie´py
et al. 2002). Hydrophobic drugs, on the other hand,
could be delivered for at least a month without
modiﬁcation of the formulation (Ruel-Garie´py et al.
2004). Intratumoral injection of the drug-loaded gel
was as effective as four intravenous injections of the
same drug (Molinaro et al. 2002). However, an
important drawback was the acute inﬂammatory
response of the gels when injected subcutaneously
(Molinaro et al. 2002); the higher the DA, the stronger
will be the response.
6.3. Alginates
A rapid curing homogeneous and stable gel was
formulated with a solution of alginate (2%) and CaCl2
(Stevens et al. 2004). Variations of the alginate and
calcium salt concentration, choice of gelling ion and
guluronic units content inﬂuence the gelation kinetics
(Stevens et al. 2004). The use of poorly water-soluble
salts (CaCO3 and CaSO4) inﬂuences gelation rate and,
consequently, mechanical properties (Kuo & Ma 2001).
If tricalciumphosphate is used to promote gelation, it
additionally creates an osteoconductive environment
that can facilitate cell attachment (Luginbuehl et al.
2005). Such injectable gels were also mixed with
insulin-like growth factor, resulting in a sevenfold
increase in proliferation rate of osteoblast-like cells
(Luginbuehl et al. 2005). When cultured with chon-
drocytes, Ca-alginate was able to support periosteum-
derived chondrogenesis, although the constructs did
not form a hyaline-like cartilaginous tissue (Stevens
et al. 2004).
A periodate-oxidized sodium alginate has been
used to crosslink gelatin in the presence of borax
to produce injectable systems (Balakrishnan &
Jayakrishnan 2005). Hepatocytes were successfully
encapsulated in the gel and remained viable for more
than four weeks.
Similarly, Na-alginate and chitosan solutions were
mixed to produce an injectable gel (Park et al. 2005a).
The gel was used to encapsulate MSCs and BMP-2, and
the system was injected subcutaneously, being able
to stimulate new trabecular bone formation (Park
et al. 2005a).
6.4. Other systems
Hyaluronic acid. It has been shown to be possible to
control the degradation and mechanical behaviour of
photopolymerized HA networks (Burdick et al. 2005)
and encapsulate articular chondrocytes using such type
of network in vivo (Nettles et al. 2004). These ﬁndings
are important since the photopolymerizable systems
can be easily used in other applications (Masters et al.
2005) and with minimally invasive procedures (Park
et al. 2005b), thus facilitating the ﬁlling of irregularly
shaped defects.
Cellulose sulphate. Cellulose sulphate (CS) consist-
ing of a sulphate ion substitutes at a carboxyl group at
every third position. Cellulose sulphate was shown to
have the potential to immunoisolate cells from rejection
process through encapsulation (Pelegrin et al. 1998;
Schaffellner et al. 2005). This also allowed CS to be
used for the designing of multicomponent capsules
for maintenance of cells during the cryopreservation
processes (Canaple et al. 2001). A pioneering work
using a one-step CS/poly(diallyl-dimethyl-ammonium
chloride) (CellMAC) assembly on a copolymerized
transient alginate scaffold fosters advances for
hardware-driven microencapsulation, as well as
protein production in animals and bioreactors (Weber
et al. 2004).
Collagen. Collagen gels belong to a special kind of
injectable hydrogel, which solidify due to changes in
shear stress. The gels are shear-thinning, which means
that their viscosity decreases as the applied shear
increases, and when the shear is removed, they regain
their semi-solid aspect (Wallace & Rosenblatt 2003;
Boesel & Reis 2004). These gels are available as
injectable suspensions of collagen ﬁbres or viscous
solutions of non-ﬁbrillar collagen in aqueous media.
However, the collagen network is too open to retain
most of the active agents of interest, requiring
secondary mechanisms to produce gels adequate for
encapsulation or tissue engineering purposes (Wallace &
Rosenblatt 2003).
One example is the crosslinking of alkali-treated
collagen with a PEG-based star polymer under
physiological conditions (Taguchi et al. 2005). In situ
encapsulated chondrocytes remained viable and were
able to express mRNA and aggrecan after three weeks
of encapsulation (Taguchi et al. 2005). Another system
consisted of denatured single-stranded collagen copo-
lymerized with dextran (Marston et al. 2005).
In addition to the aforementioned polymers, other
natural-based materials have been used for preparing
encapsulation and injectable systems. Such type of
polymers include starch (Ignoffo et al. 1991), agarose
(Orive et al. 2003; Sakai et al. 2005), carrageenan
(Bartkowiak & Hunkeler 2001; Muralidhar et al. 2001),
silk ﬁbroin (Yeo et al. 2003), gelatin (Payne et al.
2002c) and gellan gum (Chilvers & Morris 1987;
Moslemy et al. 2002).
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7. IN VITRO AND IN VIVO BIOLOGICAL
PERFORMANCE
Nowadays, it has been demonstrated that the suit-
ability of natural origin polymers for tissue engineering
purposes is highly dependent on the tissue that needs to
be engineered. The histological, physiological and
biomechanical properties of each tissue determine the
success of the regenerative process, therefore restrain-
ing the choice of the materials.
7.1. Cartilage regeneration
Cartilage is a tissue with remarkable functions that
arise in part from the composition and structure of the
highly hydrated ECM. The major challenge in the
regeneration of cartilage is to avoid the formation of
ﬁbrous cartilage, which lacks the biochemical and
mechanical properties necessary to yield a complete
and durable repair (Solchaga et al. 2001). This
inability to reconstitute the cartilage tissue and the
need to maintain the phenotype of chondrocytes have
promoted the proposition of various materials (Chang
et al. 2003a; Gigante et al. 2003; Iwasaki et al. 2004;
Mouw et al. 2005; Wang et al. 2005) to perform as
three-dimensional culture systems for cartilage
regeneration.
Chondrogenesis from chondrocytic cell lines (Li &
Zhang 2005), primary chondrocytes (Gigante et al.
2003; Masuoka et al. 2005; Mouw et al. 2005) or MSCs
(Meinel et al. 2004a; Wang et al. 2005) seeded in
natural origin scaffolds has been achieved, although not
yet fully understood.
Alginate has often been proposed for cartilage
applications due to its similarity with GAGs that
compose the ECM of chondrocytes. Alginate gels,
containing hyaluronan or ﬁbrin, induce higher chon-
drocyte proliferation when compared with alginate
alone, which was also attributed to the presence of
matrix-like molecules, from hyaluronan and ﬁbrin,
that function as anchor sites for the cells (Lindenhayn
et al. 1999). Nonetheless, alginate gels implanted in
rabbits after in vitro pre-culture with allogenic
chondrocytes induced the formation of a tissue,
which was practically indistinguishable from the
normal cartilage (Fragonas et al. 2000). The different
results might be explained by the fact that transport of
soluble factors varies with cell density, cell–cell
signalling and, consequently, an alteration in matrix
metabolism (Williams et al. 2005; Sakai et al. 2006).
In fact, alginate gels with increasing cell density
present enhanced mechanical integrity due to exten-
sive matrix deposition.
The hypothesis that cationic chitosan hydrogels
would form an ideal environment in which large
quantities of newly synthesized anionic proteoglycan
could be entrapped has been under examination
(Roughley et al. 2006). In fact, chitosan has been
shown to be able to retain the majority of the
proteoglycan produced by entrapped intervertebral
disc cells, independently of the method used to generate
the hydrogel. Thus, chitosan is also being used in the
ﬁeld of cartilage regeneration to improve cell adhesion
to alginate structures. Chitosan–alginate scaffolds
exhibit superior biological and mechanical properties
over their chitosan counterpart, showing great
potential to accelerate tissue growth and retain the
chondrocytic phenotype (Iwasaki et al. 2004; Li &
Zhang 2005). The combination of chitosan and gelatine
has also been shown to be a promising alternative for
auricular cartilage regeneration using an autologous
approach (Xia et al. 2004).
Primary porcine chondrocytes seeded on gelatin/
chondyoitin-6-sulphate/hyaluronan tri-copolymer,
aimed to mimic natural cartilage matrix, after seeding
and culture in spinner ﬂasks, which allowed a better
distribution of the cells, were able to retain chondrocyte
phenotype for ﬁve weeks. However, the amount of
synthesized matrix was not enough to form cartilage
(Chang et al. 2003a). The in vivo study (Chang et al.
2006) of the same materials using a porcine model
showed that although a good appearance was seen in
the condyles treated with either allogenic or autologous
graft, the overall results were not overwhelming, since
it was only possible to regenerate hyaline cartilage and/
or ﬁbrocartilage.
Silk-based materials were not able, per se, to
transmit the necessary signal to trigger the chondro-
genic pathway (Wang et al. 2005). The presence of
differentiation factors such as dexamethasone and
transforming growth factor (TGF-b3) was proved to
be essential for the survival and differentiation of the
MSCs, at least for up to two weeks of culture, which
correspond to the maximum proliferation rate in those
scaffolds. In addition, very small differences in the
transcript levels of speciﬁc cartilage ECM genes were
detected when comparing the cells in the silk-based
scaffolds with those in the pellet culture under the same
conditions (Wang et al. 2005).
Although collagen scaffolds with a premature
degradation do not provide the necessary structural
integrity for ECM deposition during chondrocyte
cultivation (Meinel et al. 2004a), atelocollagen scaffolds
supported the formation of cartilage in vitro with
enough elasticity and stiffness to be handled in vivo
(Masuoka et al. 2005). However, the mechanical
strength of the regenerated articular cartilage remains
to be investigated. In fact, a comparative study
between atelocollagen and alginate gels (Sakai et al.
2006) suggests that although cells proliferate better in
atelocollagen, alginate is more appropriate to obtain
high levels of proteoglycan synthesis and accumulation.
Despite the many evolving approaches in cartilage
tissue engineering, many of the relevant variables
involved in the process are yet to be deﬁned. Cells, for
instance, range from primary expanded chondrocytes
to manipulated progenitor cells and their differen-
tiation, towards a chondrogenic phenotype within the
construct environment, are highly dependent on the
properties of the material. In the case of progenitor cells
in which relatively rapid changes in phenotype are
expected, the inﬂuence of the material environment on
cell behaviour and matrix composition may be more
pronounced than in the primary chondrocytes, thus
leading to different results.
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7.2. Bone regeneration
The major concerns associated with polymeric scaffolds
for bone tissue engineering are low mechanical strength
and shape retention failure.
Silk-based scaffolds have been shown to support
human MSC (hMSC) attachment, spreading and
growth in vitro. However, depending on variables
such as processing conditions (Jin et al. 2004; Kim
et al. 2005), surface properties (Meinel et al. 2004b) and
degradability rates (Meinel et al. 2004b), different
responses in terms of bone-like tissue formation were
observed.
Collagen scaffolds, due to their fast degradation, do
not allow isomorphous replacement with a newly
formed bone. Presumably, due to the stable macro-
porous structure and slow degradation, the progression
and extent of osteogenesis were markedly and signi-
ﬁcantly higher for silk and RGD–silk scaffolds when
compared with collagen scaffolds (Meinel et al. 2004b).
Other studies have nonetheless proved that the
crosslinking (Xiao et al. 2003; Meinel et al. 2004c) or
the reinforcement of collagen scaffolds with materials
having improved mechanical properties (Kose et al.
2004; Li et al. 2005, 2006) renders scaffolds adequate for
bone tissue engineering. Some chitosan scaffolds
present mechanical weakness and instability due to
the high degree of swelling. The increase in mechanical
strength, achieved not only by changing the processing
methodology (Seol et al. 2004), but also by chemically
bonding chitosan with other natural origin polymers
such as alginate (Li & Zhang 2005), promoted the
in vitro proliferation and differentiation of osteoblastic
cells (Seol et al. 2004; Li & Zhang 2005), as well as the
rapid vascularization and deposition of connective
tissue and calciﬁed matrix in vivo.
Hyaluronic acid has been mainly used as a carrier of
bone (recombinant bone morphogenetic protein
(rhBMP)-2; Hunt et al. 2001) and vascularization
inducing agents (copper ions; Giavaresi et al. 2005)
for cancellous bone allografts and not as a scaffolding
material. In fact, although the advantages of the
hyaluronic acid as natural material and the fact that
the cell-signalling functions of this material are
dependent on molecular weight are evident (Huang
et al. 2003), there are still many uncertainties about
how it affects osteoblast activities, thus diminishing its
application as a bone tissue engineering scaffold.
The mimicking of ECM by using natural origin
materials has been further attempted using comp-
lementary approaches, in order to improve the per-
formance of these materials. A nano- and microﬁbre
combined starch-based scaffold (Tuzlakoglu et al. 2005)
showed that its unique architecture, being able to
support and guide cells, can also provide an ideal
structure for cell deposition and organization to be used
in bone tissue engineering.
A real situation in the assessment of the suitability of
scaffolds to be used in bone tissue engineering has to do
with the speciﬁc in vitro calcium deposition on the top
and bottom of the scaffold, when using static culture
conditions, instead of being throughout the structure
(Gomes et al. 2003; Meinel et al. 2004b). A better cell
distribution and, consequently, the uniformity of
mineralization (Gomes et al. 2003; Meinel et al.
2004c) as well as the orientation of bone matrix (Meinel
et al. 2004c), although restricted by the interconnec-
tivity degree of the scaffold, can be achieved under a
ﬂow environment. Bone marrow cells cultured with
starch-based scaffolds also responded to ﬂow perfusion
conditions by augmenting the production of several
bone-related growth factors, namely TGF-b1, FGF-2,
vascular endothelial growth factor (VEGF) and BMP-2
(Gomes et al. 2006).
The success of subsequent transplantation of the
in vitro engineered construct is believed to rely not only
on the properties of the materials but also on the
osteoprogenitor cell sources. It is expected that the
seeded cells will secrete speciﬁc ECM components
in vitro, to induce proliferation and differentiation
into osteoblasts and result in the formation of a new
bone in vivo (Mizuno et al. 1997). In the majority of the
studies, the choice of cell source is not clear, since it is
not based on relevant aspects, such as the capacity of
the transplanted cells to trigger endogenous cascades
for recruitment and differentiation. In fact, the precise
role of implanted vital cells in the induction and the
mineralization in vivo is not yet determined. Xiao et al.
(2003) showed that differentiated osteoblasts and
in vitro developed matrix are not involved in direct
bone formation. However, the used construct did
appear to induce differentiation of host mesenchymal
cells during the repair of critical size bone defects due to
the bone-related proteins (ALP, osteocalcin, OPN,
BMP-2 and BMP-4) deposited along the collagen
scaffold or present in the intercellular matrix within
the scaffold.
7.3. Skin substitution
Wound repair has been achieved following two main
tissue engineering strategies, either using scaffolds or
matrices, which can be cellular or acellular (Jimenez &
Jimenez 2004). Decellularized matrices have been
shown to stimulate angiogenesis and to modulate
endogenous growth factor functions (Chandler et al.
2000; Jimenez & Jimenez 2004). So far, scaffolds made
of ﬁbrin (Bensaid et al. 2003; Hokugo et al. 2006),
hyaluronic acid (Mao et al. 2003; Liu et al. 2004),
chitosan (Berthod et al. 1996; Ishihara et al. 2001;
Gingras et al. 2003) and collagen (Guerret et al. 2003;
Hudon et al. 2003; Ruszczak 2003; Jarman-Smith et al.
2004) from a variety of origins, alone or combined
(Berthod et al. 1996; Hafemann et al. 1999, 2001; Klein
et al. 2001; Mao et al. 2003), were shown to be promising
for wound healing applications.
The use of cells (e.g. keratinocytes and ﬁbroblasts)
within a three-dimensional matrix (Jimenez & Jimenez
2004) is also a usual approach in skin tissue engineering.
However, wound dressing treatment, especially when
the skin substitution is required, is not a problem-free
process. That is, it requires the restoration of the
continuity of a living tissue and an integrated response
of several cells to injury, which are necessary to
promote cellular colonization and remodel the matrix.
Therefore, inﬂammation and neovascularization, for
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example, are required processes for healing, if only
controlled (Klein et al. 2001). In fact, animal origin
membranes composed of ﬁbrous collagen and elastin as
dermal substitute scaffolds were shown to elicit a
chronic inﬂammatory response, leading to the damage
of the tissues instead of tissue repair (Klein et al. 2001).
Immunogenicity issues, in fact, can be raised when
considering protein-based biomaterials. Collagen, as an
animal origin protein, would be expected to elicit
speciﬁc and uncontrolled immune reactions. However,
collagen is one of the most popular materials for the
majority of dermal substitutes, as it possesses different
levels of structural order and is a natural substrate for
cellular attachment, growth and differentiation
(Ruszczak 2003). Some in vitro studies demonstrated
that human dermal ﬁbroblasts and keratinocytes can be
cultured with collagen membranes, indicating its
suitability for permanent dermis replacement or
wound healing situations, after chemical modiﬁcations
(Hafemann et al. 2001; Hudon et al. 2003; Jarman-
Smith et al. 2004). Another study (Keefe et al. 1992)
also revealed a normal inﬂammatory response after the
in vivo implantation of collagen-based scaffolds. Thus,
the practical use of collagen for wound healing is limited
not due to its immunogenicity but due to the problems
related to storage stability and the time required to
prepare enriched collagen solutions (Ruszczak 2003).
Other natural origin materials are also proposed
for skin substitution. Fibrin-based scaffolds with
poly(glycolic acid) (PGA) for guided skin regeneration
have been tested in vitro and in vivo (Hokugo et al.
2006). In addition, ﬁbrin scaffolds proved to be good
matrices for the spreading and proliferation of hMSCs,
enhancing their suitability for wound healing and skin
substitution (Bensaid et al. 2003). Chitosan alone
(Berthod et al. 1996; Ishihara et al. 2001; Gingras
et al. 2003), modiﬁed with hyaluronic acid (Mao et al.
2003) or collagen (Berthod et al. 1996), has also been
reported to be suitable for wound healing and skin
substitution. Berthod et al. (1996) developed a col-
lagen–chitosan sponge on which human ﬁbroblasts,
cultured for one month, produced differentiated
connective tissue. An in vivo study demonstrated that
a tissue engineering construct of collagen–chitosan and
human skin ﬁbroblasts and keratinocytes, transplanted
in the back of nude mice, enhanced nerve regeneration,
proving it to be a suitable construct also for skin
substitution (Gingras et al. 2003).
7.4. Cardiovascular tissue regeneration
The overall goal of vascular tissue engineering is to
obtain the same mechanical and biological properties as
a native vessel (Boccafoschi et al. 2005). The use of
collagen conjugated with different types of cells in vitro,
such as primary rat aortic smooth muscle cells
(Weinberg & Bell 1986; Tranquillo et al. 1996;
Boccafoschi et al. 2005) and endothelial cells (Weinberg
& Bell 1986; Boccafoschi et al. 2005), to mimic the
blood vessels is not a new approach. It represents a
suitable option for vascular tissue engineering, due to
the low in vitro thrombogenicity and the ability of the
scaffold to support the spreading of primary smooth
muscle and endothelial cells (Boccafoschi et al. 2005).
Nowadays, other studies are being carried out to
evaluate long-term cytocompatibility and the potential
of both elastin and collagen scaffolds to be repopulated
by host cells in vivo (Simionescu et al. 2006). Tan &
Desai (2003, 2004, 2005) proposed a new strategy for
the construction of blood vessels using different types of
natural origin matrices, such as collagen, chitosan,
Matrigel and ﬁbrin. These materials were used to
create a three-dimensional pattern within microchan-
nels composed of poly(dimethylsiloxane). The multi-
layer structure within the microchannels was built
through microﬂuidic delivery of cells within the
biopolymer matrices, layer by layer with a controlled
ﬂow rate, achieving a three-dimensional conﬁguration
(Tan & Desai 2003, 2004). Three types of cells (human
lung ﬁbroblasts, human umbilical vein smooth muscle
cells and human umbilical vein endothelial cells) were
used to create the multicellular three-dimensional
culture system, which was shown to be useful to build
up multiple layers of cells in well-deﬁned geometries
with controlled ECM composition. This three-dimen-
sional well-controlled micropatterned multilayer
system allowed the re-establishment of the in vivo-like
cell–cell interaction concept that exists in the vascular
system or other laminar-structured tissues (Tan &
Desai 2005).
The use of natural origin polymers for heart valve
replacement or septal occlusion has also been proposed.
In vitro and in vivo (in a lamb model) studies with
natural scaffolds based on collagen showed low inﬁltra-
tion with inﬂammatory cells (Jux et al. 2003).
7.5. Knee ligament
Collagen (Noth et al. 2005) and silk (Altman et al. 2002;
Chen et al. 2003) have been proposed as natural origin
materials to be used as scaffolds for knee ligament tissue
engineering scaffolds.
The ideal knee ligament replacement scaffold should
exhibit sufﬁcient mechanical strength, demonstrate
mechanical behaviour similar to natural ligament and
promote the formation of ligamentous tissue. The
scaffold should degrade at a rate that allows the new
tissue to receive an appropriate level of load without
danger of rupture (Laurencin & Freeman 2005), with
concomitant structured matrix deposition (Altman
et al. 2002). Silk ﬁbre matrices have been shown to
provide a suitable scaffold to support adult stem cell
differentiation towards a ligament lineage (Altman
et al. 2002). Although promising, silk performance was
shown to be improved by coating the surface with RGD
sequences (Chen et al. 2003). Ge and co-workers (Ge
et al. 2005) concluded that bone marrow is a better
source of MSCs for anterior cruciate ligament when
compared with ﬁbroblasts from the anterior cruciate
and the medial collateral ligaments (Ge et al. 2005).
In another study with bone marrow-derived MSCs
seeded on a type I collagen hydrogel, Noth and
colleagues (Noth et al. 2005) suggested that these
cells repeatedly adopt a deﬁned longitudinal orien-
tation and organize the surrounding matrix in parallel,
highly organized ﬁbres in a wavy pattern with bundles
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of ECM when submitted to cyclic stretching. However,
these constructs are still too weak to allow the in vivo
implantation.
8. FINAL REMARKS
In the ﬁeld of tissue engineering, a great deal of effort
has been put in to prepare different formulations based
on natural polymers. However, despite all the extensive
literature containing references to the so-called
‘natural-based’ systems, it is the authors’ opinion that
much work is still needed to obtain clinically successful
materials. Many improvements can be made in this
context, as such systems offer a great versatility. They
may be, for example, chemically modiﬁed and com-
bined with ceramics or other polymers (blends,
copolymers and inter-penetrated networks). Their
interaction with cells and tissues may be improved or
tuned, by adequate chemical modiﬁcations, such as
grafting with peptides (e.g. RGD), or by surface
treatments (e.g. surface plasma modiﬁcation or modiﬁ-
cation of surface chemistry through grafting with other
polymers). Many attempts have been made to produce
smart naturally derived systems that could be used in
tissue engineering applications, including (i) develop-
ment of new injectable thermogelling materials that
could be used to deliver cells or growth factors through
non-invasive routes, (ii) novel matrices that can be
degraded by adequate cell signals and actions, (iii)
scaffolds or hydrogels that can deliver relevant bio-
active agents in speciﬁc conditions (temperature, pH,
ionic strength or presence of speciﬁc enzymes), and (iv)
self-assembling systems that can be tuned by external
signals. Different processing routes have been proposed
to produce scaffolds with a great variety of porous
architectures. This is an especially delicate task, as
naturally derived macromolecules are typically non-
meltable (without degradation) and may be insoluble in
many solvents. This compromises the use of many of
the most traditional techniques to produce tissue
engineering scaffolds. Efforts should, in fact, be made
to develop or improve new or combined processing
strategies to obtain repeatable porous constructs with
controlled porous morphology, preferably at different
scale levels (e.g. combination of nano- and microele-
ments or pores), comprising different materials that are
spatially organized and having the capability to deliver
relevant molecules such as growth factors in a
controlled way. Such new scaffolds should be designed
for different applications, addressing particular aspects,
such as: to induce vascularization; facilitate the
deposition of calcium phosphates in predeﬁned regions;
guide the regeneration of tissue in certain directions
(through gradient delivery of factors or anisotropic
porous architecture); permit the development of
different tissues (e.g. regeneration of osteochondral
defects); or inhibit calciﬁcation and cell adhesion (e.g.
in cardiovascular application), just to cite some
examples. The ﬁeld is widely open for new creative
researchers to make some dreams come true in real
clinical applications.
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